EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Phosphoramidates and phosphonamidates (ProTides) with antiviral activity

Magdalena Slusarczyk, Michaela Serpi, Fabrizio Pertusati

Antiviral Chemistry and Chemotherapy · 2018-01 · 26

DOI: 10.1177/2040206618775243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antiviral Chemistry and Chemotherapy, online erschienen am 23.05.2018. Verfasst von Magdalena Slusarczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following the first report on the nucleoside phosphoramidate (ProTide) prodrug approach in 1990 by Chris McGuigan, the extensive investigation of ProTide technology has begun in many laboratories. Designed with aim to overcome limitations and the key resistance mechanisms associated with nucleoside analogues used in the clinic (poor cellular uptake, poor conversion to the 5′-monophosphate form), the ProTide approach has been successfully applied to a vast number of nucleoside analogues with antiviral and anticancer activity. ProTides consist of a 5′-nucleoside monophosphate in which the two hydroxyl groups are masked with an amino acid ester and an aryloxy component which once in the cell is enzymatically metabolized to deliver free 5′-monophosphate, which is further transformed to the active 5′-triphosphate form of the nucleoside analogue. In this review, the seminal contribution of Chris McGuigan’s research to this field is presented. His technology proved to be extremely successful in drug discovery and has led to two Food and Drug Administration-approved antiviral agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmidesAntiviral AgentsHumansMicrobial Sensitivity TestsMolecular StructurePhosphoric AcidsProdrugsViruses

Stichwörter der Autor:innen

Nucleoside analoguesantiviralphosphoramidate (ProTide)prodrugs

Substanzen

AmidesAntiviral AgentsPhosphoric AcidsProdrugsphosphoramidic acid

Autor:innen und Institutionen

  • School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.

Zitieren

APA

Slusarczyk, M., Serpi, M., & Pertusati, F. (2018). Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Antiviral Chemistry and Chemotherapy, 26. https://doi.org/10.1177/2040206618775243

Vancouver

Slusarczyk M, Serpi M, Pertusati F. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Antiviral Chemistry and Chemotherapy. 2018;26. doi:10.1177/2040206618775243

BibTeX
@article{Slusarczyk2018,
  author = {Slusarczyk, Magdalena and Serpi, Michaela and Pertusati, Fabrizio},
  title = {Phosphoramidates and phosphonamidates (ProTides) with antiviral activity},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2018},
  volume = {26},
  doi = {10.1177/2040206618775243}
}
Kostenlos starten →